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Abstract
Background: Cowden syndrome (CS) or multiple hamar-
toma syndrome is a cancer-associated genodermatosis
inherited in an autosomal dominant pattern. One of the
diagnostic criteria is facial papules which are felt to be
trichilemmomas, benign hair follicle tumors, which
some consider to be induced by human papillomavirus
(HPV). Objective: To search for HPV in skin tumors, espe-
cially trichilemmomas, from patients with CS. Methods:
Skin lesions from patients with CS were classified histo-
logically. Each tumor was then analyzed for HPV DNA by
polymerase chain reaction with different primer sets;
positive amplicons were typed by direct sequencing.
Results: Twenty-nine biopsies from 7 patients with CS
were investigated. Only 2 of 29 tumors clinically sus-
pected of being trichilemmomas were confirmed histo-
logically. In addition, 3 sclerotic fibromas, also typical of
CS, were found, as well as 1 sebaceous hyperplasia. The
other 23 lesions showed histological features of HPV-
induced tumors in various stages of development. HPV
DNA was found in 19 of 29 cutaneous lesions. Tumors
without any histological signs of HPV induction were
negative for HPV DNA. Two tumors which were histolog-
ically classified as common warts contained HPV types
27 and 28. All the 17 other HPV types belong to the group
of epidermodysplasia-verruciformis-associated types.
Conclusions: The majority of cutaneous lesions in CS
contain HPV DNA. They may have a variety of histologi-
cal patterns. Trichilemmomas are not clinically distinc-
tive and can be difficult to identify in CS patients. 
Copyright © 2003 S. Karger AG, Basel
Introduction
Cowden syndrome (CS, OMIM No. 158350) or multi-
ple hamartoma syndrome is a cancer-associated genoder-
matosis inherited in an autosomal dominant pattern [1].
The gene for CS has been identified as PTEN (phospha-
tase and tensin homologue) at chromosome 10q22–23 [2].
The most common associated malignancies are carcino-
mas of the breast, thyroid and endometrium. The cuta-
neous changes are often the first sign so that an astute der-
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Table 1. Summary of patients
Patient DOB Systemic involvement Lesions Code No.
M.R. [27] 3.9.1924 thyroid carcinoma, bilateral cystic bre-
ast disease, laryngeal papillomas
4 + 2A 22672
22673
22674
22675
12129/98
12130/98
W.L. [28] 13.4.1935 breast carcinoma,
malignant melanoma
6 +1A 22676
22677
22678
22679
22680
22681
13292/99
B.G. [28] 21.12.1959 cervical carcinoma, thyroid adenoma 6 + 3A 22682
22683
22684
22685
22686
22687
6652/99
6653/99
6654/99
G.K.P. [28] 29.1.1935 bronchial carcinoma 1A 11851/99
B.R. [28] 30.9.1983 macrocephaly, no tumors 2A 7640/99
17589/99
F.G. [29] 3.9.1941 intestinal polyposis, thyroid adenoma 3A 2272/82
1050/79
3564/85
Not known Hodgkin lymphoma,
intestinal polyposis
1A 88956
Total 29
DOB = Date of birth; A = archival material. G.K.P. is the father of B.G. and the grandfa-
ther of B.R.
matologist may make the initial diagnosis. The typical
cutaneous lesions are wart-like; they have been variously
described as facial papules and oral papules, as well as
acral and palmoplantar keratoses. The facial papules may
be trichilemmomas, benign hair follicle tumors; this find-
ing is prominently featured in the diagnostic criteria.
There has been a smoldering controversy over the possi-
ble role of human papillomavirus (HPV) in both solitary
and CS-associated trichilemmomas. We studied a varied
of skin lesions from patients with CS with both routine
light microscopy and HPV DNA analysis.
Patients and Methods
We followed two approaches. We biopsied 16 lesions in 3 of our
patients (M.R., W.L. and B.G.) with well-established CS. In each
instance, the lesion was either facial or had verrucous features. The
choice of lesions was somewhat limited by the willingness of the
patient to endure multiple biopsies which were not of diagnostic or
therapeutic utility. The material was fixed in standard formalin solu-
tion and embedded in paraffin. In addition, we obtained blocks of
similarly prepared tissue both from these patients and 4 other indi-
viduals with CS. The clinical features of all these patients are summa-
rized in table 1. All had typical cutaneous changes and the only one
without systemic tumors was a teenage boy (B.R.) with striking
macrocephaly whose mother and grandfather (B.G. and G.K.P.)
have clear CS.
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Table 2. PCR results and histological diagnosis of all investigated specimens
Code No. Histological
diagnosis
Primer sets
A
(genital
HPV types)
B-1
(HPV group B1, sub-
group A, EV-associated
HPV types 5, 8, 12, 14d, 19,
20, 21, 24, 25, 36, 47 and
putative new types)
B-2
(HPV group B1, sub-
group B, EV-associated
HPV types 9, 15, 17, 22, 23,
37, 38, 49, 75, 76, 80 and
putative new types)
D
(cutaneous
HPV types 3,
10, 27, 28)
22672 VPSC – – AF0420061 –
22673 VPSC – – 80 –
22674 VPSC – – 37 –
22675 SK – – 80 –
22676 SH – – – –
22677 VPSC – – 9 –
22678 VPSC – – related to HPV 37 –
22679 VPSC (IFK) – – related to HPV 37 –
22680 SF – – – –
22681 SF – – – –
22682 SK – – – –
22683 VPSC – – Z95965 (5) –
22684 TL – – – –
22685 VPSC – – AF0420061 –
22686 VPSC – – – –
22687 SK – – – –
6652/99 VPKC – – – 28
6653/99 VPSC (IFK) – – 9 –
6654/99 VPSC – – 9 –
7640/99 VPKC – – – 27
17589/99 VPKC – – related to HPV 25 –
11851/99 VPSC – – AF0420061 –
88956 VPSC (IFK) – – 37 –
12129/98 VPSC – – 37 –
12130/98 TL – – 80 –
2272/82 VPSC – – – –
1050/79 VPSC – – – –
3564/85 VPSC – – Z95968 (5) –
13292/99 SF – – – –
TL = Trichilemmoma; VPKC = viral papilloma with HPV-induced keratinocyte changes; VPSC = possible viral
papilloma with structural changes; IFK = inverted follicular keratosis; SK = seborrheic keratosis; SH = sebaceous
hyperplasia; SF = sclerotic fibroma. The difference between primer sets B-1 and B-2 is explained in Patients and
Methods.
1 Genbank accession number; Summersgill K.F., Haugen T.H., Smith E.M., Turek L.P., direct submission, Janu-
ary 9, 1998, Pathology, VA Medical Center, Iowa City, Iowa, USA.
The lesions were studied by routine light microscopy employing
hematoxylin and eosin-stained sections. In addition, the tissue was
analyzed for the presence of HPV DNA. Five sections of each paraf-
fin-embedded tissue sample were deparaffinized with xylene as
described by Shibata [3]. DNA was then extracted using the QIAamp
tissue kit (Qiagen, Germany). The DNA of each tissue sample was
eluted in 100 Ìl water, divided into 50-Ìl aliquots and stored at
–20°C until use.
Primer Sets and PCR Assays
Detection and typing of mucosal, epidermodysplasia-verrucifor-
mis (EV)-associated and cutaneous HPV types were done by using
nested PCR assays with different consensus primer sets (A, B-1, B-2
and D) and direct sequencing of the amplicons. The used primer sets
B-1 and B-2 enable the detection of subgroup A [4] (primer set B-1)
and B [3] (primer set B-2) of HPV group B1 described by Chan et al.
[5] (group B1, subgroup A: HPV, 5, 8, 12, 14d, 19, 20, 21, 24, 25, 36,
47; group B1, subgroup B: HPV 9, 15, 17, 22, 23, 37, 38, 49, 75, 76,
80). Using nested PCR assays, a high sensitivity for detection of the
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Fig. 1. Clinical (a) and histological (b) correlation of investigated tumors in CS: viral papilloma with keratinocyte
changes (VPKC), viral papilloma with structural changes (VPSC) and trichilemmoma (TL).
VPKC VPSC TL
a
b
different HPV types was achieved ranging between 2 and 10 HPV
genome equivalents.
The different primer pairs and the corresponding PCR assays
have been described in detail [6]. Primer sets for detection of HPV
group B2 (HPV 4, 48, 50, 60, 65) were not included in this study
because these types, especially HPV 60, are more associated with
plantar epidermoid cysts [7, 8].
Positive controls (previously HPV-5 and -17-positive tested tis-
sue samples) and negative controls (water or HPV-negative tissue)
were processed the same way as the samples throughout the first-step
and second-step PCR. We used kidney and liver tissue specimens
from rats as well as previously HPV-negative tested human skin spec-
imens as negative controls. The PCR products (10 Ìl of each) were
analyzed on 2% agarose gels stained with 1 Ìg/ml of ethidium.
Sequencing
For determination of the HPV types, the amplification products
of the expected size were purified using the Qiagen PCR purification
kit or the QIAquick gel extraction kit (Qiagen) and subsequently
sequenced by cycle sequencing with the PrismTM Ready Reaction
Dye DeoxyTM Terminator Cycle Sequencing Kit (Applied Biosys-
tems, Germany) using the same primers which were used for the
PCR assay. The sequences were then compared to the EMBL data-
base (virus part) using the FASTA program (EMBL).
Results
Table 2 shows the histological diagnoses and the re-
sults of the HPV DNA studies in the 29 lesions. The two
skin tumors classically associated with CS are trichilem-
momas and sclerotic fibromas. We found only 2 trichi-
lemmomas and 3 sclerotic fibromas. In addition, we iden-
tified 1 sebaceous hyperplasia.
The other 23 tumors all had histological features of
HPV-induced tumors in various stages of development.
We distinguished between a viral papilloma with HPV-
induced keratinocyte changes and a possible viral papillo-
ma with structural changes (fig. 1). The presence or ab-
sence of koilocytes was used to determine which tumors
were viral papillomas with keratinocyte changes; 2 pa-
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tients had a total of 3 classical verrucae vulgares. The
group with structural changes was more heterogeneous.
These tumors showed acanthosis, focal hypergranulosis,
parakeratosis and occasional hemorrhage in the stratum
corneum. There was no evidence of cell atypia. We further
classified these lesions as plane warts (4), filiform warts
(4) and old warts (2). We defined an old wart as a typical
verruca vulgaris without koilocytes. A similar lesion with
horn pseudocysts was designated as seborrheic keratosis;
3 were identified. In addition we found 3 inverted follicu-
lar keratoses which we included as old warts but identified
separately because they clearly involved the hair follicle.
All 29 samples were analyzed for the presence of HPV
DNA, which was found in 19 of 29 lesions. Using the dif-
ferent primer sets, 5 distinct HPV types (9, 37, 80, 27, 28)
and 3 putative new types (DL253 and DL285, accession
No. Z95965, Z95968 [9], and isolate IA18 [Summersgill
et al., unpubl. results], accession No. AF042006) were
detected and typed. Furthermore, in 3 cases we found
sequences, which were closely related but not identical to
the well-characterized types 25 and 37. They may repre-
sent new types or highly mutated variants of the estab-
lished types.
The correlation of the histological appearance of the
lesions with the HPV type showed that HPV DNA was
only detected in skin tumors with architectural or cytologi-
cal criteria of a HPV histogenesis (trichilemmoma, viral
papilloma with keratinocyte changes or structural changes,
inverted follicular keratosis, seborrheic keratosis). Tumors
without any histological sign of HPV induction (sebaceous
hyperplasia and sclerotic fibroma) were negative in the
HPV PCR analysis as were the negative controls.
Types 27 and 28 were the only cutaneous-type HPV to
be identified, and they were found in 2 lesions, which
were histologically common warts with virally trans-
formed keratinocytes. All other HPV types belong to
group B1, EV-associated types (table 2).
Discussion
The exact nature of the cutaneous lesions in CS has
long been controversial. Brownstein et al. [10] and Starink
et al. [11] were the first to identify multiple trichilemmo-
mas as a marker for CS. Brownstein et al. [10] found that
about 54% of facial lesions removed from 19 patients
were trichilemmomas, while Starink et al. [11] studied
29 facial biopsies in 7 patients, finding 66% trichilemmo-
mas. Gradually multiple trichilemmomas became ac-
cepted as a major diagnostic criterion for CS. In the latest
guidelines, the presence of 6 facial papules, 3 of which are
trichilemmomas, is considered diagnostic [12].
There are two basic problems with this approach. First,
patients with CS do not have 4 clinically distinct types of
lesions – facial papules, acral fibromas, palmoplantar ker-
atoses and oral papules. Instead, there is a marked degree
of clinical overlap, as our sampling shows. Papules may be
smooth or warty, regardless of whether they are acral,
facial or mucosal. Lesions may also be seen in flexural
areas, as well as scattered over the body. In general, the
facial lesions are more likely to resemble common or fili-
form warts, while the acral lesions are more similar to
plane warts. Ackerman et al. [13] argued convincingly
that clinically the lesions are most suggestive of warts in
varying stages of evolution, with slightly different appear-
ances based on location.
Second, histology does not resolve the issue. Some
lesions are papillomatous with granular layer changes, sug-
gesting that they are warts. Most acral lesions are not papil-
lomatous but may still show granular layer changes com-
patible with a plane wart. Even the lesions that are accepted
as trichilemmomas, showing a clear-cell tumor involving a
hair follicle, often have some verrucous features. Acker-
man et al. [13–15] feel that all trichilemmomas are HPV
infections involving the hair follicle. We have previously
identified HPV DNA in 11 of 11 solitary trichilemmomas
in patients without CS [16]. In the only other study, using a
less sensitive detection system, Leonardi et al. [17] failed to
find HPV DNA in solitary trichilemmomas.
Much progress has been made in the detection of HPV
both from lesions and in normal skin. As demonstrated
previously by several investigators, the use of different
broad-spectrum primer sets enables the identification of
most of the more than 90 known HPV types, as well as
putative novel HPV types [9, 18–20]. In spite of the
improved methodology for the detection of cutaneous and
EV-associated papillomaviruses, little is known about the
possible role of these HPV types in carcinogenesis. Geni-
tal HPV types, especially HPV 16 and 18, have been
extensively investigated in view of viral gene expression,
host cell interaction and their influence during the cell
cycle; no comparable studies are available for the cuta-
neous and EV-associated types.
We offer the following two speculations about the rela-
tionship of CS and HPV.
(1) Patients with CS may well have a single cutaneous
lesion with varying clinical and histological patterns de-
pending on location and age.
As Ackerman et al. [21] have pointed out, when experi-
enced clinicians are unable to distinguish between 2 histo-
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logically distinct lesions in the same patient, it is likely
that these lesions represent different stages in the evolu-
tion of a single lesion. Two other examples of this phe-
nomenon are the keratoacanthomas and sebaceous tu-
mors in Muir-Torre syndrome and the fibrofolliculomas
and trichodiscomas in Birt-Hogg-Dubé syndrome [21]. In
both instances, it is impossible to accurately separate the
lesions clinically, and it has been accepted that they repre-
sent the same tumor.
From our patients with CS whom we biopsied specifi-
cally for this study (patients W.L., M.R., B.G.), we learned
that it can be extremely difficult to identify trichilem-
momas. Two experienced clinicians with an interest in
genodermatoses (W.B., P.I.) selected the lesions feeling
they fit the published criteria for trichilemmomas. Of the
16 biopsies taken in this fashion, only 2 revealed trichi-
lemmomas, a batting average of 0.125. We conclude that
trichilemmomas are often not clinically distinctive and
that it is an error to assume that all facial lesions of CS are
trichilemmomas. In some of the studies in the literature
[11], the illustrations suggest that lesions which we desig-
nated as viral papillomas with structural changes have
been included as trichilemmomas.
(2) HPV DNA is found in the cutaneous lesions of CS.
We identified HPV DNA in 19 of 29 lesions in this
study. We have also found similar HPV DNA sequences
in solitary trichilemmomas [16]. It is surely conceivable
that HPV could cause both solitary and CS-related trichi-
lemmomas. Since HPV is common in hair follicles and
found often on facial skin, it is difficult to argue that its
presence in many of the lesions of CS proves an etiological
connection. In one study, EV-associated HPV DNA was
found in plucked eyebrow hair in about 50% of adults
[22]. It is well accepted that the hair follicle is both one of
the permanent sources of HPV DNA and the site of origin
of trichilemmomas. The likelihood of finding HPV is
greater in sun-exposed skin. Biopsies from W.L. (22676–
22681) were from non-sun-exposed sites and some still
contained HPV DNA. As known for high-risk HPV types
(e.g. 16, 18) the oncoproteins E6 and E7 as well as the viral
regulatory protein E2 could influence and override the
different checkpoints of the cell cycle using varied mecha-
nisms resulting in genomic instability [23–26]. Since
nearly all studies about virus-induced carcinogenesis and
the function of the viral regulatory proteins were done
with high-risk HPV types, especially HPV 16, very little is
known about the importance of the cutaneous and EV-
associated HPV types and also about the function of the
regulatory proteins of these viruses. Further studies of the
transcription and protein expression are necesssary to
clarify the role of HPV in the induction of trichilemmo-
mas and other lesions associated with CS.
In sum, the number of questions raised by our study
clearly exceeds the answers we have provided. Patients
with CS develop warty lesions, which are difficult to diag-
nose clinically. In many of these lesions, EV-associated
HPV types can be found, and a classification is only possi-
ble by histological and molecular-biological investiga-
tion.
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